Dow Up2.00% Nasdaq Up1.66%

ImmunoCellular Therapeutics, Ltd. (IMUC)

-ASE
0.22 Up 0.01(4.06%) Feb 12, 4:00PM EST
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
Net Income (9,378) (8,801) (14,495)
Operating Activities, Cash Flows Provided By or Used In
Depreciation48  50  46  
Adjustments To Net Income187  86  3,173  
Changes In Accounts Receivables -   -   -  
Changes In Liabilities(219)304  (480)
Changes In Inventories -   -   -  
Changes In Other Operating Activities(575)(427)(624)
Total Cash Flow From Operating Activities (9,937) (8,787) (12,380)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(29)(44)(10)
Investments -   -   -  
Other Cash flows from Investing Activities0   -   -  
Total Cash Flows From Investing Activities (29) (44) (10)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock5,541  10,261  31,953  
Net Borrowings -   -   -  
Other Cash Flows from Financing Activities -   -   -  
Total Cash Flows From Financing Activities 5,541   10,261   31,953  
Effect Of Exchange Rate Changes -   -   -  
Change In Cash and Cash Equivalents (4,424) 1,430   19,564  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.